AU3150300A - Use of pyrazole carboxamides - Google Patents

Use of pyrazole carboxamides

Info

Publication number
AU3150300A
AU3150300A AU31503/00A AU3150300A AU3150300A AU 3150300 A AU3150300 A AU 3150300A AU 31503/00 A AU31503/00 A AU 31503/00A AU 3150300 A AU3150300 A AU 3150300A AU 3150300 A AU3150300 A AU 3150300A
Authority
AU
Australia
Prior art keywords
pyrazole carboxamides
carboxamides
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31503/00A
Other languages
English (en)
Inventor
Martin Bechem
Gabriele Braunlich
Christoph Dr. Gerdes
Berthold Hinzen
Thomas Kramer
Emanuel Lohrmann
Klemens Lustig
Lorenz Mayr
Ulrich Dr Nielsch
Josef Pernerstorfer
Michael Sperzel
Jurgen Stoltefuss
Thomas Studemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU3150300A publication Critical patent/AU3150300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU31503/00A 1999-02-04 2000-01-24 Use of pyrazole carboxamides Abandoned AU3150300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19904397 1999-02-04
DE19904397A DE19904397A1 (de) 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden
PCT/EP2000/000519 WO2000045894A2 (de) 1999-02-04 2000-01-24 Verwendung von pyrazol-carbonsäureamiden

Publications (1)

Publication Number Publication Date
AU3150300A true AU3150300A (en) 2000-08-25

Family

ID=7896339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31503/00A Abandoned AU3150300A (en) 1999-02-04 2000-01-24 Use of pyrazole carboxamides

Country Status (8)

Country Link
EP (1) EP1148879A2 (es)
JP (1) JP2002536348A (es)
AR (1) AR022470A1 (es)
AU (1) AU3150300A (es)
CA (1) CA2361636A1 (es)
DE (1) DE19904397A1 (es)
GT (1) GT200000009A (es)
WO (1) WO2000045894A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878729B2 (en) 2001-05-04 2005-04-12 The Procter & Gamble Company Medicinal uses of dihydropyrazoles
AU2005287170B2 (en) * 2004-09-17 2012-03-29 Exelixis, Inc Pyrazole kinase modulators and methods of use
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
PE20120003A1 (es) 2009-01-30 2012-02-12 Glaxosmithkline Llc Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino
EP4173485A1 (en) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
WO1997019039A1 (en) * 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
DE19904396A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolbenzylamin-Derivate
DE19904406A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolcarbonsäuren

Also Published As

Publication number Publication date
WO2000045894A3 (de) 2001-04-19
EP1148879A2 (de) 2001-10-31
GT200000009A (es) 2001-07-27
CA2361636A1 (en) 2000-08-10
JP2002536348A (ja) 2002-10-29
AR022470A1 (es) 2002-09-04
WO2000045894A2 (de) 2000-08-10
DE19904397A1 (de) 2000-08-10

Similar Documents

Publication Publication Date Title
AU2001227858A1 (en) Delivery of cardiac constraint jacket
AU5970399A (en) Pyrazole carboxanilides
AU2001267766A1 (en) Pyrazole derivatives
AU3867400A (en) Methods of using bioelastomers
AU5932098A (en) Fungicidal carboxamides
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU4308300A (en) Pyrazoles having antiinflammatory activity
HUP0204072A3 (en) Coating of tablet cores
AU4554500A (en) Substituted pyrazole derivative
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU3150300A (en) Use of pyrazole carboxamides
AUPQ078799A0 (en) New use
AU2669501A (en) New use
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2001281123A1 (en) Haplotypes of the isl1 gene
AUPQ462399A0 (en) New use
AU3158701A (en) New use
AU2002215923A1 (en) Use of medicaments
AU6014200A (en) Disposable jacket
AU3421100A (en) Pyrazole alkylamides
AU2001290603A1 (en) Haplotypes of the or11a1 gene
AU2357701A (en) Novel use of dioxolones
AU2002239511A1 (en) Haplotypes of the gsr gene
AU2001264939A1 (en) Haplotypes of the pdxk gene
AU5076100A (en) Utilization of mixtures

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase